The Alzheimer's disease THErapy with NEuroaid (ATHENE) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild-to-moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine—A randomized, double-blind, placebo-controlled trial

The Alzheimer's disease THErapy with NEuroaid (ATHENE) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild-to-moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine—A randomized, double-blind, placebo-controlled trial

10.1016/j.trci.2018.12.001

Saved in:
書目詳細資料
Main Authors: Chen, C.L.H., Sharma, P.R., Tan, B.Y., Low, C., Venketasubramanian, N.
其他作者: PHARMACOLOGY
格式: Article
出版: Elsevier Inc 2021
主題:
Alzheimer's disease
Clinical trial
Disease progression
MLC901
Neuroaid II
在線閱讀:https://scholarbank.nus.edu.sg/handle/10635/212354
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!
機構: National University of Singapore

因特網

https://scholarbank.nus.edu.sg/handle/10635/212354

相似書籍